Fidelity Investments’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.9K | Sell |
3,274
-16
| -0.5% | -$89 | ﹤0.01% | 4605 |
|
|
2025
Q4 | $22K | Sell |
3,290
-1,269
| -28% | -$7.53K | ﹤0.01% | 4421 |
|
|
2025
Q3 | $20K | Sell |
4,559
-2,668
| -37% | -$12.7K | ﹤0.01% | 4359 |
|
|
2025
Q2 | $32.1K | Buy |
7,227
+4,924
| +214% | +$20.6K | ﹤0.01% | 4096 |
|
|
2025
Q1 | $13K | Buy |
2,303
+1,792
| +351% | +$22.9K | ﹤0.01% | 4395 |
|
|
2024
Q4 | $10.8K | Buy |
511
+81
| +19% | +$1.86K | ﹤0.01% | 4448 |
|
|
2024
Q3 | $11.6K | Buy |
430
+5
| +1% | +$147 | ﹤0.01% | 4382 |
|
|
2024
Q2 | $12.1K | Buy |
425
+419
| +6,983% | +$14.7K | ﹤0.01% | 4262 |
|
|
2024
Q1 | $250 | Sell |
6
-21
| -78% | -$944 | ﹤0.01% | 4906 |
|
|
2023
Q4 | $1.42K | Buy |
27
+22
| +440% | +$993 | ﹤0.01% | 4707 |
|
|
2023
Q3 | $206 | Buy |
5
+1
| +25% | +$46 | ﹤0.01% | 4787 |
|
|
2023
Q2 | $220 | Buy |
+4
| New | +$219 | ﹤0.01% | 4892 |
|
|
2022
Q3 | – | Sell |
-37
| Closed | -$1K | – | 5110 |
|
|
2022
Q2 | $1K | Sell |
37
-101
| -73% | -$4.56K | ﹤0.01% | 4720 |
|
|
2022
Q1 | $8K | Buy |
138
+99
| +254% | +$5.86K | ﹤0.01% | 4293 |
|
|
2021
Q4 | $3K | Buy |
+39
| New | +$2.77K | ﹤0.01% | 3928 |
|
|
2016
Q2 | – | Sell |
-10,738
| Closed | -$324K | – | 2665 |
|
|
2016
Q1 | $324K | Buy |
10,738
+1,160
| +12% | +$32.9K | ﹤0.01% | 2587 |
|
|
2015
Q4 | $332K | Hold |
9,578
| – | – | ﹤0.01% | 2649 |
|
|
2015
Q3 | $362K | Sell |
9,578
-46,024
| -83% | -$2.14M | ﹤0.01% | 2621 |
|
|
2015
Q2 | $3.17M | Buy |
55,602
+45,914
| +474% | +$2.61M | ﹤0.01% | 2357 |
|
|
2015
Q1 | $564K | Hold |
9,688
| – | – | ﹤0.01% | 2597 |
|
|
2014
Q4 | $549K | Buy |
+9,688
| New | +$462K | ﹤0.01% | 2625 |
|
|
2013
Q3 | – | Sell |
-198,854
| Closed | -$7.13M | – | 2637 |
|
|
2013
Q2 | $7.13M | Buy |
+198,854
| New | +$7.61M | ﹤0.01% | 2032 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
